期刊文献+

APP695^(K595N/M596L)突变转基因小鼠的建立和病理表型动态分析

Establishment of APP695^(swedish) Transgenic Mouse Model and Analysis of the Development of Pathological Phenotypes
下载PDF
导出
摘要 目的建立APP695K595N/M596L(Swedish突变)转基因小鼠和评价痴呆表型的发生和发展过程。方法将APP695K595N/M596L突变基因插入到小鼠朊蛋白(mouse prion protein)启动子下游,构建转基因表达载体,通过显微注射法建立APP695K595N/M596L突变转基因C57BL/6J小鼠。PCR鉴定转基因小鼠的基因表型,Western blotting检测APP突变基因表达。Thioflavin-S染色检测不同年龄转基因小鼠大脑病理改变。Morris水迷宫动态观察小鼠行为学改变。结果建立了人APP695K595N/M596L转基因小鼠,Thioflavin-S染色显示转基因小鼠9月龄时在脑海马区可检测到老年斑形成,并且在11、12月龄时明显增多。Morris水迷宫结果发现与同月龄野生型小鼠相比,该转基因小鼠5月龄开始出现学习记忆能力缺陷,7、9、11月行为学结果证实转基因小鼠的学习记忆能力缺陷随年龄增加而日趋严重(P<0.05)。结论建立了人APP695K595N/M596L转基因小鼠,并能再现人类阿尔茨海默症的行为学及神经病理学特征,为阿尔茨海默病发病机制研究和药物研发提供了有价值的动物模型。 Objective To generate a transgenic mouse line expressing human APP695^K595N/M596L (Swedish mutation) and establish a transgenic Alzheimer disease model. Methods The transgenic plasmid was constructed by inserting the mutated APP695^K595N/M596L gene into the downstream of mouse prion protein promoter. The transgenic mice were produced by microinjection and the genotype was detected by PCR. The gene expression levels were determined by Western blotting. The senile plaques were detected by thioflavin-S staining and visualized directly by fluorescence microscopy. The behavioral changes was examined by Morris water maze test. Results Transgenic C57BL/6J mice were generated with the expression of the APP695^K595N/M596L in the brain tissue. The transgenic mice showed significant learning and memory impairments in the Morris water maze at 5 months of age and the extent of the impairments was developed at 7, 9 and 11 months of age, comparing with that of age-matched wild type mice (P 〈 0. 05). Senile plaques were visualized in the CA1 area of hippocampus at 9 and increased at 12 months of age. Conclusions The transgenic mice show a progressive deficits of learning and memory and a progressive formation of senile plaques in the hippocampus, suggesting that this APP transgenic mouse is an useful animal model of Alzheimer disease.
出处 《中国比较医学杂志》 CAS 2011年第12期5-9,25,92,共7页 Chinese Journal of Comparative Medicine
基金 卫生部项目 实验动物和人类疾病动物模型资源扩展(200802036) 十一五新药专项支持(2009ZX09501-026)
关键词 朊蛋白 APP瑞士突变 转基因小鼠 水迷宫 Prion APP swedish mutant Transgenic mouse Water maze
  • 相关文献

参考文献14

  • 1Kim D,Tsai LH.Bridging physiology and pathology in AD[J].Cell,2009,137(6):997-1000.
  • 2Stokin GB,Lillo C,Falzone TL,et al.Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease[J].Science,2005,307(5713):1282-8.
  • 3Ulrich VM.Gene therapy methods in bone and joint disorders.Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders,periprosthetic osteolysis and bone healing[J].Acta Orthop (Suppl),2007,78(325):1-64.
  • 4Moechars D,Dewachter Ⅰ,Lorent K,et al.Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain[J].J Biol Chem,1999,274 (10):6483-92.
  • 5Ryan KA, Pimplikar SW.Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain[J].J Cell Biol,2005,171 (2):327-35.
  • 6Sasahara M,Fries JW,Raines EW,et al.PDGF B-chain in neurons of the central nervous system,posterior pituitary,and in a transgenic model[J].Cell,1991,64(1):217-27.
  • 7Hsiao K,Chapman P,Nilsen S,et al.Correlative memory deficits,Abeta elevation,and amyloid plaques in transgenic mice[J].Science,1996,274(5284):99-102.
  • 8Mesulam M,Shaw P,Mash D,et al.Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum[J].Ann Neurol,2004,55(6):815-828.
  • 9Priller C,Bauer T,Mitteregger G,et al.Synapse formation and function is modulated by the amyloid precursor protein[J].J Neurosci,2006,26 (27):7212-7221.
  • 10Abramov E,Dolev I,Fogel H,et al.Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses[J].NatNeurosci,2009,12(12):1567-76.

二级参考文献18

  • 1Kowalska A. Genetic basis of neurodegeneration in familial Alzheimer's disease [J]. Pol J Pharmacol, 2004, 56(2):171 - 178.
  • 2Wagner SL, Munoz B. Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer' s disease [J]. J Clin Invest, 1999,104(10) : 1329 - 1332.
  • 3Gandy S. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease [J]. J Clin Inves, 2005, 115(5) : 1121 - 1129.
  • 4Gordan JW, Ruddle FH. Integration and stable germ lin transmission of genes injected into mouse pronuclei[J]. Science, 1981, 214 (4526) : 1244 - 1246.
  • 5Chishti MA, Yang DS, Janus C, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein695 [J]. J Biol Chem, 2001, 276(24) :21562 - 21570.
  • 6Moechars D, Dewachter I, Lorent K, et al. early phenotypic changes in Transgenic mice that overexpress different mutants of amyloid precursor protein in brain [J]. J Biol Chem, 1999, 274(10) :6483 - 6492.
  • 7Goate A, Chartier-Harlin MC, Mullah M, et al, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer' s disease[J]. Nature, 1991, 349(6311) :704 - 706.
  • 8Grundke-Iqbal I, Iqbal K. Tau pathology generated by overexpression of tau [J]. Am J Pathol, 1999, 155(6):1781- 1785.
  • 9Chen Z, Raman M, Chen L, et al. TAO (Thousand-and-one Amino Acid) protein kinases mediate signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors [J]. J Biol Chem, 2003, 278(25):22278- 22283.
  • 10Fryer JD, Simmons K, Parsadanian M, et al. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model[J]. J Neurosci, 2005,16: 25(11):2803-2810.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部